Healthcare giant’s $21bn loss sinks ASX200
The ASX 200 slumped on CSL’s results. Picture: NewsWire / Max Mason-Hubers Australia’s sharemarket snapped a six-day winning…
Here’s How This Forgotten Healthcare Stock Could Generate Life-Changing Returns
This biotech’s innovative approach could pay rich dividends down the road. Over the past few years, the market…
Epic unveils AI agents, showcases new foundational models
Epic unveils AI agents, showcases new foundational models | Healthcare IT News Skip to main content TOPICS RESOURCES…
Alcohol consumption and your health: What the science says
“A lot of people who don’t currently drink are people who used to drink heavily, or who have…
Sydney mum lured overseas by promises of a miracle cure surgery is now fighting for her life in a foreign hospital
A Sydney mum-of-eight who travelled overseas for a promised ‘cure’ to her diabetes is now fighting for her…
Smartwatches Won’t Fix the Burnout Crisis in Medicine
This transcript has been edited for clarity. Welcome to Impact Factor, your weekly dose of commentary on a…
Is a statin drug right for you? Researchers try to right-size the risk
It’s a math problem with life-and-death consequences. When a new and improved model for estimating the risk of…
Her spine surgery was denied. Doctors say it’s all too common.
“There’s a lot of gray zone decision-making in spine surgery,” DiGiorgio said. “You could show a patient presentation,…
US drug pricing shake-up threatens access to medicines in Europe – POLITICO
For European drugmakers there are still many unknowns about how the MFN scheme — and overall tariffs on…
Rocket Pharma’s shares soar after US FDA lets gene therapy trial resume
Rafael Henrique | SOPA Images | AP The U.S. health regulator has allowed a study of Rocket Pharmaceuticals’…
Is your health care provider really listening to you?
Credit: Unsplash/CC0 Public Domain When you visit a doctor, you expect them to listen. But in today’s fast-paced…
AI unicorn EliseAI nabs $250M from a16z to break into healthcare — TFN
Enterprise software maker EliseAI, based in New York, has raised $250 million in Series E funding. The funding…